Methods for production of piperidyl acetamide stereoisomers
    1.
    发明授权
    Methods for production of piperidyl acetamide stereoisomers 有权
    哌啶乙酰胺立体异构体的生产方法

    公开(公告)号:US06359139B1

    公开(公告)日:2002-03-19

    申请号:US09707524

    申请日:2000-11-07

    IPC分类号: C07D21132

    CPC分类号: C07D211/34

    摘要: Synthetic methods are provided comprising the steps of racemizing l-threo-piperidyl acetamides to form a mixture of d-threo, l-threo, d-erythro, and l-erythro-piperidyl acetamides by reacting said l-threo-piperidyl acetamides with alkanoic acid.

    摘要翻译: 提供了合成方法,包括以下步骤:使1-苏式 - 哌啶基乙酰胺进行外消旋化以形成d-苏,1-苏,d-赤型和1-赤型 - 哌啶基乙酰胺的混合物,通过使所述1-苏 - 哌啶基乙酰胺与链烷酸 酸。

    Treatment Using D-Threo Methylphenidate
    4.
    发明申请
    Treatment Using D-Threo Methylphenidate 审中-公开
    使用D-Threo哌甲酯治疗

    公开(公告)号:US20110118310A1

    公开(公告)日:2011-05-19

    申请号:US13005068

    申请日:2011-01-12

    申请人: Vikram Khetani

    发明人: Vikram Khetani

    IPC分类号: A61K31/4458 A61P25/00

    CPC分类号: A61K9/0019 A61K31/445

    摘要: Methods for treating a disease responsive to the administration of methylphenidate and/or one or more isomers thereof, said method comprising identifying a patient suffering from a disease or disorder having a family history or diagnosis of tics or Tourette's Syndrome and administering to said patient a therapeutically effective amount of D-threo methylphenidate substantially free of the 1-threo isomer and of erythro methylphenidates.

    摘要翻译: 用于治疗响应于哌甲酯和/或其一种或多种异构体的疾病的方法,所述方法包括鉴定患有家族史或Tico或Tourette综合征诊断的疾病或病症的患者,并且向所述患者施用治疗 有效量的基本上不含1-苏式异构体的D-苏式哌甲酯和红哌啶酯。

    Methods Of Diminishing Co-Abuse Potential
    7.
    发明申请
    Methods Of Diminishing Co-Abuse Potential 审中-公开
    减少共同滥用潜力的方法

    公开(公告)号:US20130158073A1

    公开(公告)日:2013-06-20

    申请号:US13765994

    申请日:2013-02-13

    IPC分类号: A61K31/4458

    CPC分类号: A61K31/4458

    摘要: Methods of diminishing or eliminating the co-abuse of a methylphenidate drug comprising identifying a patient or patient group suspected or likely to abuse said methylphenidate drug in combination with a substance known or suspected to give rise to l-ethylphenidate or psychotropic effect when ingested in the combination and making available to said patent or patient group said methylphenidate drug substantially free of l-threo methylphenidate.

    摘要翻译: 减少或消除哌甲酯药物的共同滥用的方法包括鉴定怀疑或可能滥用所述哌甲酯类药物的患者或患者组合与已知或怀疑产生1-乙酯或精神药效作用的物质组合, 组合并提供给所述专利或患者组,所述哌甲酯药物基本上不含1-苏式哌甲酯。